Kutane leukozytoklastische Vaskulitis, Purpura Schönlein-Henoch und kryoglobulinämische Vaskulitis
暂无分享,去创建一个
[1] A. Mahr,et al. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results , 2012, Current opinion in rheumatology.
[2] Zonghui Hu,et al. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. , 2012, Arthritis and rheumatism.
[3] A. Gabrielli,et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. , 2012, Arthritis and rheumatism.
[4] J. Stone,et al. The cryoglobulinaemias , 2012, The Lancet.
[5] D. Roccatello,et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. , 2011, Autoimmunity reviews.
[6] H. Mahmoodzadeh,et al. Treatment of Complicated Henoch-Schönlein Purpura with Mycophenolate Mofetil: A Retrospective Case Series Report , 2010, International journal of rheumatology.
[7] S. Gunturu,et al. Henoch-Schonlein Purpura—A Case Report and Review of the Literature , 2010, Gastroenterology research and practice.
[8] H. Raspe,et al. EULAR recommendations for the management of primary small and medium vessel vasculitis , 2008, Annals of the Rheumatic Diseases.
[9] F. Dede,et al. Mycophenolate mofetil treatment of crescentic Henoch–Schönlein nephritis with IgA depositions , 2008, Scandinavian journal of urology and nephrology.
[10] R. Bratton,et al. Henoch-Schönlein Purpura: A Review Article , 2007, Southern medical journal.
[11] J. Piette,et al. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study. , 2006, Arthritis and rheumatism.
[12] A. Bryce,et al. Response to rituximab in patients with type II cryoglobulinemia. , 2006, Clinical lymphoma & myeloma.
[13] L. Quartuccio,et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. , 2006, Rheumatology.
[14] T. Asselah,et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C , 2006, Hepatology.
[15] L. Gibson,et al. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment , 2006, International journal of dermatology.
[16] M. Houghton,et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. Fossati-Jimack,et al. The Role of Complement in Cryoglobulin-Induced Immune Complex Glomerulonephritis1 , 2005, The Journal of Immunology.
[18] I. Uthman,et al. Response of deep cutaneous vasculitis to infliximab. , 2005, Journal of the American Academy of Dermatology.
[19] J. Piette,et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. , 2005, Arthritis and rheumatism.
[20] M. Braun,et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. , 2004, The Journal of rheumatology.
[21] Claudio Michelassi,et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. , 2004, Seminars in arthritis and rheumatism.
[22] G. Kaplanski,et al. Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. , 2004, Rheumatology.
[23] R. Fanin,et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. , 2003, Blood.
[24] B. Zimmerman,et al. Hepatitis C, cryoglobulinemia, and cirrhosis: A meta‐analysis , 2002, Hepatology.
[25] R. Ruiz Villaverde,et al. Annular leucocytoclastic vasculitis: response to dapsone , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.
[26] R. Falk,et al. Cutaneous and Systemic Manifestations of Drug-Induced Vasculitis , 2002, The Annals of pharmacotherapy.
[27] D. Pyne,et al. Colchicine for the treatment of recurrent Henoch-Schönlein purpura in an adult. , 2001, Rheumatology.
[28] Felicia A Tucci,et al. The cryoglobulins: an overview , 2001, European journal of clinical investigation.
[29] J. Yagüe,et al. Cryoglobulinemia: Study of Etiologic Factors and Clinical and Immunologic Features in 443 Patients from a Single Center , 2001, Medicine.
[30] S. Jessop. Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. , 1995, British journal of rheumatology.
[31] S. Finegold,et al. Vasculitides associated with infections, immunization, and antimicrobial drugs. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] R J Falk,et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.
[33] S. Bombardieri,et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. , 1992, The Journal of rheumatology.
[34] J. Callen,et al. Cutaneous Leukocytoclastic Vasculitis: Clinical Experience in 44 Patients , 1987, Southern medical journal.
[35] J. Clauvel,et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. , 1974, The American journal of medicine.